| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |